戻る
Akeso Inc (AKESF)価格
AKESF 株価推移チャート
AKESF 収入
Akeso Inc
$15.47
-0.19%
$-0.02
終値： Jan 16, 16:00:00 GMT-5
$15.55
0.51%
$0.08
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$15.5
始値
$15.53
当日レンジ
$15.47 - $16.1
52週レンジ
$6.81 - $23.15
取引高
--
平均取引高
1.1K
1株当たり利益(TTM)
-0.14
配当利回り
--
時価総額
$14.3B
AKESFとは何ですか？
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.